ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Clinical trials for ACUTE PROMYELOCYTIC LEUKEMIA (APL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE PROMYELOCYTIC LEUKEMIA (APL) trials appear
Sign up with your email to follow new studies for ACUTE PROMYELOCYTIC LEUKEMIA (APL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Swallowing arsenic? new leukemia pill tested
Disease control CompletedThis study tested a new oral liquid version of an existing leukemia drug, arsenic trioxide. It involved 12 patients to see how the body absorbs the pill compared to the standard IV infusion, and if taking it with food or an antacid changes that. The goal was to gather data to see…
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: PHASE1 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Harvard tests AI as Cancer-Detecting partner for doctors
Diagnosis CompletedThis study tested whether artificial intelligence (AI) could help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Doctors reviewed bone marrow samples with and without AI assistance to see if the technology improved thei…
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: NA • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Diagnosis
Last updated Apr 02, 2026 05:41 UTC